Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linzagolix vs Injectable GnRH Antagonist in IVF/ICSI
NCT07732348Not yet recruiting
- Sponsor
- Centro A.M.B.R.A.
- Start
- Sep 2026
- Primary completion
- Dec 2026
01
Overview
Randomised, open-label trial of linzagolix in female infertility (3 arms), sponsored by Centro A.M.B.R.A. Primary endpoint: Number of Mature (MII) Oocytes Retrieved. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
linzagolix
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT07732348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07732348.